Big Pharma Surges as Zepbound Sales Skyrocket: What You Need to Know
Eli Lilly's Zepbound sales skyrocketed to $1.9 billion, reflecting a major demand for weight-loss treatments. Competition intensifies in the pharmaceutical market with Novo Nordisk also reporting doubled sales of Wegovy…